All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0722-YF184 | TS-IL15 SA Anti-Human CA9 scFv (CB515) CD28-CD3ζ CAR, pCDCAR1 | Human | CB515 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0822-YF1883 | Anti-Human CA9 (XW-43) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-43 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF10647 | TS-IL15 SA Anti-Human CA9 scFv (XW-39) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-39 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10648 | TS-IL15 SA Anti-Human CA9 scFv (XW-40) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-40 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10649 | TS-IL15 SA Anti-Human CA9 scFv (XW-41) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-41 | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0922-LX1 | Anti-CA9 (X9X1) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 | Human | X9X1 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-LX2 | Anti-CA9 (X9X2) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 | Human | X9X2 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-LX399 | Anti-CA9 (X9X1) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 | Human | X9X1 | Mouse | scFv-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-LX400 | Anti-CA9 (X9X2) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 | Human | X9X2 | Mouse | scFv-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-LX598 | Anti-CA9 (X9X1) Negative Control CAR, pCDCAR1 | Human | X9X1 | Mouse | scFv-CD28/CD8TM | Lentiviral vector | T cell | ||
XS-0922-LX599 | Anti-CA9 (X9X2) Negative Control CAR, pCDCAR1 | Human | X9X2 | Mouse | scFv-CD28/CD8TM | Lentiviral vector | T cell | ||
XS-1122-YF39 | Anti-CA9 KIR CAR (scFv-KIR2DS2-DAP12, G250), pCDCAR1 | Human | G250 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF40 | Anti-CA9 KIR CAR (scFv-KIR2DS2-DAP12, XW-40), pCDCAR1 | Human | XW-40 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF41 | Anti-CA9 KIR CAR (scFv-KIR2DS2-DAP12, XW-41), pCDCAR1 | Human | XW-41 | Human | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF42 | Anti-CA9 KIR CAR (scFv-KIR2DS2-DAP12, XW-42), pCDCAR1 | Mouse | XW-42 | Human | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF43 | Anti-CA9 KIR CAR (scFv-KIR2DS2-DAP12, CB515), pCDCAR1 | Human | CB515 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF959 | Anti-CA9 TCR-ABR (scFv-TCRα, G250) CAR Plasmid, pCDCAR1 | Human | G250 | Mouse | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF960 | Anti-CA9 TCR-ABR (scFv-TCRα, XW-40) CAR Plasmid, pCDCAR1 | Human | XW-40 | Mouse | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF961 | Anti-CA9 TCR-ABR (scFv-TCRα, XW-41) CAR Plasmid, pCDCAR1 | Human | XW-41 | Human | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF962 | Anti-CA9 TCR-ABR (scFv-TCRα, XW-42) CAR Plasmid, pCDCAR1 | Mouse | XW-42 | Human | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-0823-LX3 | Anti-hCA9 (H1L1) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | H1L1 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION